Related Experiment Video

Updated: Dec 13, 2025

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
03:42

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models

Published on: September 27, 2024

1.9K

Involvement of the Interferon Signaling Pathways in Pancreatic Cancer Cells

Mariko Fujisawa1, Tatsuo Kanda2, Toshikatsu Shibata1

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.

Anticancer Research
|July 31, 2020
PubMed
Abstract

Insights

Interferon (IFN) signaling suppresses pancreatic cancer cell growth and migration. Targeting IFN and TLR3 pathways offers potential therapeutic strategies for pancreatic ductal adenocarcinoma (PDAC).

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) remains a significant challenge in cancer therapy.
  • Understanding interferon (IFN) signaling in PDAC is crucial for developing novel treatments.

Purpose of the Study:

  • To investigate the role of IFN signaling pathways in human pancreatic cancer cells.
  • To explore the therapeutic potential of targeting IFN and Toll-like receptor (TLR) pathways in PDAC.

Main Methods:

  • Examined IFNα effects on pancreatic cancer cell cytotoxicity and migration.
  • Analyzed the impact of IFNα on TLR signaling pathway-associated gene expression.
  • Utilized RNA-sequencing (RNA-Seq) for transcriptome analysis of clinical samples (PanINs vs. PDACs).
  • Assessed combined effects of IFNα, poly(I-C), and tyrosine kinase inhibitors (TKIs).

Main Results:

  • IFNα demonstrated suppressive effects on pancreatic cancer cell viability and migration.
  • IFNα modulated TLR signaling pathways, with TLR3 identified as a potentially involved gene.
  • Poly(I-C) addition enhanced TKI-induced cytotoxicity, similar to IFN effects.
  • RNA-Seq revealed IFN signaling involvement in the progression from pancreatic intraepithelial neoplasia (PanIN) to PDAC.

Conclusions:

  • IFN signaling pathways are implicated in PDAC development.
  • Targeting IFN and TLR3 signaling pathways presents promising therapeutic avenues for PDAC treatment.
Keywords:
InterferonRNA-SeqTKIToll-like receptorpancreatic cancer

More Related Videos

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

11.9K
In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model08:23

In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model

Published on: April 12, 2016

9.7K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.7K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.3K